Company profile: Protea Biosciences
1.1 - Company Overview
Company description
- Provider of mass spectrometry standards and services, including mass spectrometry imaging via LAESI and MALDI, HGMS integrating optical microscopy and histology, and LC-MS for proteomics, metabolomics, and protein characterization, enabling direct ionization, high-resolution spatial mapping, and targeted chemical profiling across diverse sample types.
Products and services
- LCMS Services: LC-MS-coupled analytics delivering protein characterization, proteomics, and metabolomics across diverse biological samples, utilizing liquid chromatography paired with mass spectrometric measurement
- Mass Spectrometry Imaging Services: Platform-based imaging using LAESI and MALDI to map biomolecular landscapes in various sample types, enabling direct ionization and high-resolution spatial data from tissue specimens
- HGMS Services: Histology-guided mass spectrometry integrating optical microscopy and histology to target specific sample morphologies, delivering localized chemical profiling aligned with structural features
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Protea Biosciences
Syndesi Therapeutics
HQ: Belgium
Website
- Description: Provider of drug candidates and molecules that uniquely modulate the synaptic vesicle protein SV2A to regulate synaptic transmission, representing a promising approach to treating Alzheimer’s disease and other neurological disorders with cognitive impairment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syndesi Therapeutics company profile →
Validair
HQ: United Kingdom
Website
- Description: Provider of particle counters, sensors, and environmental monitoring solutions; clean air testing, calibration, and technical services; performance testing for cleanrooms, operating theatres, containment suites, LEVS, and workstations to ensure compliance; GMP consultancy on validation and qualification; ongoing re-qualification, routine monitoring, maintenance; and chlorine dioxide dry gas decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Validair company profile →
Nortis Bio
HQ: United States
Website
- Description: Provider of organ-on-a-chip systems and tissue-engineering techniques that create human micro-tissue environments within small, disposable microfluidic chips, enabling living models of human organs to accelerate discovery and help scientists better understand the causes of human diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nortis Bio company profile →
Breath Therapeutics
HQ: Germany
Website
- Description: Provider of inhaled investigational therapies for rare respiratory diseases, combining novel formulations of existing drugs with cutting-edge inhalation technology. Pipeline includes Liposomal Cyclosporine A for Inhalation for bronchiolitis obliterans syndrome to deliver drug to lungs while minimizing systemic exposure, and inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis targeting Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Breath Therapeutics company profile →
Sepax Technologies
HQ: United States
Website
- Description: Provider of chromatography columns and resins for biomolecule separation and analysis, including ion exchange (Proteomix IEX), hydrophobic interaction (Proteomix HIC Butyl), size exclusion for ADCs and other biomolecules (Monomix MC SEC resins; Zenix-C SEC), reverse phase for DAR analysis (Proteomix RP-1000), and weak cation exchange for monoclonal antibodies (Antibodix WCX), plus method development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sepax Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Protea Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Protea Biosciences
2.2 - Growth funds investing in similar companies to Protea Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Protea Biosciences
4.2 - Public trading comparable groups for Protea Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →